a total of 589 patients with previously untreated multiple myeloma were randomized to receive daily oral melphalan , pulse-dose intravenous ( iv ) melphalan , carmustine ( bcnu ) , or lomustine ( ccnu ) .
C0026764
multiple myeloma
C0025241
melphalan